Xcout Intel
Vesalius
Vesalius Therapeutics is a biotechnology company founded by Flagship Pioneering to redefine how common illnesses are treated. Headquartered in Cambridge, Massachusetts, the firm applies novel human data insights to drug discovery and therapeutic development.
Subscribe to see Vesalius’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vesalius at a glance
Vesalius is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $75M in March 2022. Xcout tracks 3 named people at Vesalius, including Chris Austin (Chief Executive Officer). Xcout recorded 3 job postings from Vesalius in the last 90 days.
Vesalius leadership
- Chris AustinChief Executive Officer
- John MendleinExecutive Chairman and interim Chief Executive Officer
- Doug ColeCo-founder and Managing Partner, Flagship Pioneering
Vesalius funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $75M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Vesalius
Xcout recorded 3 job postings from Vesalius in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Vesalius's hiring signals →
Investors
Vesalius competitors
A few of Vesalius's closest competitors — see the full list of competitors and alternatives →
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
ProFound Therapeutics is a biotechnology company founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Headquartered in Cambridge, Massachusetts, the company is pioneering the exploration of the expanded human proteome.
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Arena BioWorks is a biotechnology research organization located in Cambridge, Massachusetts, focused on translating human biology and disease mechanisms into breakthrough medicines.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Get Vesalius's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Vesalius in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access